QUOTIENT LIMITED 17,647,059 Ordinary Shares (no par value per Share) UNDERWRITING AGREEMENT September 10, 2020Underwriting Agreement • September 14th, 2020 • Quotient LTD • In vitro & in vivo diagnostic substances • New York
Each of the undersigned, Franz Walt, Chief Executive Officer of Quotient Limited, a company organized under the laws of Jersey (the “Company”), and Peter Buhler, Chief Financial Officer of the Company, on behalf of the Company, does hereby certify pursuant to Section 6(k) of that certain Underwriting Agreement dated [●], 2020 (the “Underwriting Agreement”) among the Company and the Underwriters named therein, that as of [●], 2020:
